Top Markets
Coin of the day
Nanjing Sinolife United Company Limited Nanjing Sinolife United Company Limited

Nanjing Sinolife United Company Limited

3332
Classificação em ações #29981
Nanjing Sinolife United Company Limited functions as an investment holding... Nanjing Sinolife United Company Limited functions as an investment holding entity primarily involved in the manufacturing, processing, and global distribution of nutritional supplements. Its operations span the People's Republic of China, Australia, New Zealand, Vietnam, and various international markets. The firm additionally produces and markets cosmetics and skincare items, while also undertaking the trading, retail, and testing of pre-packaged health food products. Products are sold under well-known brands such as Good Health, Zhongsheng, Hejian, and Cobayer, primarily via its comprehensive network of retail outlets. Distribution also encompasses sales through distributors, television shopping channels, online e-commerce platforms, chain pharmacies, specialized health food supermarkets, and tourist souvenir shops. The company, which has been headquartered in Nanjing, China, since its establishment in 1999.
Preço da ação
$0.01982857
Última sincronização: 2026-08-18
Valor de mercado
$18.76M
Variação (1 dia)
1.31%
Variação (1 ano)
-67.10%
País
CN
Negociar Nanjing Sinolife United Company Limited (3332)
Lucros da Nanjing Sinolife United Company Limited (3332)
Lucros em 2026 TTM: 0
De acordo com os últimos relatórios financeiros da Nanjing Sinolife United Company Limited, os ganhos atuais da empresa são de 0. Em 2026, a empresa teve ganhos de 0, igual a aos ganhos de 2026, que foram de 0. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Nanjing Sinolife United Company Limited de 2026 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
Não há dados suficientes para as datas fornecidas.
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$20.38B -
US
$9.83B -
FR
$2.94B -
US
$1.55B -
IN
- -
DE